semaglutide origin history Semaglutide: First Global Approval FDA Warns on Certain Forms

A primary concern for menopausal GLP-1 users is the potential for accelerated bone thinning and muscle loss, which is why experts emphasize the necessity of a high protein intake and consistent strength training to mitigate these risks

The key to success was respecting facial anatomy and timing interventions sequentially to maximise synergy while minimising recovery time

The active ingredient belongs to the class of GLP-1 receptor agonists

They may recommend a DEXA scan (bone density scan) before and during treatment

Additionally, in a post-hoc analysis of the SURPASS-4 trials, tirzepatide showed a slower rate of eGFR decline and lower urinary albumin creatinine values as compared to patients who were treated with glargine insulin [75, 76]

This enhanced adipose function reduces ectopic lipid deposition in liver and other tissues, indirectly ameliorating hepatic steatosis